Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹67.89 Cr
Nippon India Small Cap Fund
0.1% of their portfolio
₹67.89 Cr
25,94,559 sh
Nippon India Pharma Fund
0.5% of their portfolio
₹43.96 Cr
16,80,015 sh
HDFC Value Fund
45.0% of their portfolio
₹37.34 Cr
15,34,403 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
0.5% of their portfolio
₹36.48 Cr
16,62,047 sh
ICICI Prudential Healthcare Fund
0.4% of their portfolio
₹29.35 Cr
11,21,777 sh
Kare Family Private Trust
Investor
₹1.11 Cr
1,30,97,055 sh
Suresh G Kare
Investor
₹34.57 L
29,068 sh
ICICI Prudential Balanced Hybrid Fund
0.1% of their portfolio
₹12.05 L
4,953 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹67.89 Cr
ICICI Prudential Healthcare Fund
Indoco Remedies Limited · NSE
11,21,777 sh · ₹29.35 Cr
Nippon India Pharma Fund
Indoco Remedies Limited · NSE
16,80,015 sh · ₹43.96 Cr
NK Securities Research Private Limited
Indoco Remedies Limited · NSE
+6,91,564 sh · ₹18.89 Cr
Microcurves Trading Private Limited
Indoco Remedies Limited · NSE
−9,69,889 sh · ₹26.52 Cr
Blitzquant Research LLP
Indoco Remedies Limited · NSE
−4,64,497 sh · ₹12.91 Cr
Blitzquant Research LLP
Indoco Remedies Limited · NSE
+4,64,497 sh · ₹12.90 Cr
Microcurves Trading Private Limited
Indoco Remedies Limited · NSE
+9,69,889 sh · ₹26.48 Cr
Junomoneta Finsol Private Limited
Indoco Remedies Limited · NSE
+6,63,827 sh · ₹18.23 Cr
Junomoneta Finsol Private Limited
Indoco Remedies Limited · NSE
−6,64,724 sh · ₹18.27 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
47 announcements on record for this company.
Promoter holding by quarter: Jun 2025 58.9%, Sep 2025 58.9%, Dec 2025 58.9%, Mar 2026 58.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 1.2%, Sep 2025 1.3%, Dec 2025 1.1%, Mar 2026 0.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 19.0%, Sep 2025 18.2%, Dec 2025 18.1%, Mar 2026 18.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 18.6%, Sep 2025 17.6%, Dec 2025 17.6%, Mar 2026 17.5%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 58.9%, Sep 2025 58.9%, Dec 2025 58.9%, Mar 2026 58.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 1.2%, Sep 2025 1.3%, Dec 2025 1.1%, Mar 2026 0.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 19.0%, Sep 2025 18.2%, Dec 2025 18.1%, Mar 2026 18.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 18.6%, Sep 2025 17.6%, Dec 2025 17.6%, Mar 2026 17.5%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
47 announcements on record for this company.